02:57 PM EST - Lorus Therapeutics Inc. : reported a loss for fiscal 2008 that narrowed from the previous year. The Toronto, Ontario-based company's net loss for the year narrowed to $6.24 million, or $0.03 per share, from $9.64 million, or $0.05 per share, a year ago. Revenue for the full year increased to $133 thousand from $107 thousand in fiscal 2007. Lorus Therapeutics Inc.
shares T.LOR are trading down 1 cent at $0.11.
